Biomarkers Linked to Elevated T2D MACE Risk Biomarkers Linked to Elevated T2D MACE Risk

A secondary DECLARE-TIMI 58 trial analysis linked two biomarkers to higher cardiovascular risks in diabetes and found a strong benefit of dapagliflozin.MDedge News

Source: Medscape Diabetes Headlines - March 8, 2023 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news